Low-Cardiac-Output Syndrome After Cardiac Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 31, Issue 1, 2017, Pages 291-308

  Lomivorotov, Vladimir V ^a   Efremov, Sergey M ^a   Kirov, Mikhail Y ^b   Fominskiy, Evgeny V ^a   Karaskov, Alexander M ^a  

^a MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

^b NORTHERN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

cardiac surgery; goal directed hemodynamic therapy; inotropes; low cardiac output syndrome; mechanical circulatory support

Indexed keywords

DOBUTAMINE; DOPAMINE; EPINEPHRINE; INHALATION ANESTHETIC AGENT; LEVOSIMENDAN; LIOTHYRONINE; LITHIUM; NORADRENALIN; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; CARDIOTONIC AGENT;

ASSISTED CIRCULATION; CARDIOPLEGIA; ECHOGRAPHY; EXTRACORPOREAL OXYGENATION; FORWARD HEART FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART SURGERY; HEMODYNAMIC MONITORING; HUMAN; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; REVIEW; RISK FACTOR; THERMODILUTION; TRANSPULMONARY THERMODILUTION; DRUG EFFECT; HEART OUTPUT; HEMODYNAMICS; INTRAOPERATIVE MONITORING; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROCEDURES; TRENDS;

CARDIAC OUTPUT; CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; HEMODYNAMICS; HUMANS; MONITORING, INTRAOPERATIVE; POSTOPERATIVE COMPLICATIONS;

EID: 85009821091     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2016.05.029     Document Type: Review

References (207)

1. 1 Bridgewater, B., Mortality data in adult cardiac surgery for named surgeons: Retrospective examination of prospectively collected data on coronary artery surgery and aortic valve replacement. BMJ 330 (2005), 506–510.
2. 2 Chen, J.C., Kaul, P., Levy, J.H., et al. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. Crit Care Med 35 (2007), 1296–1301.
3. 3 Lomivorotov, V.V., Efremov, S.M., Pokushalov, E.A., et al. Randomized trial of fish oil infusion to prevent atrial fibrillation after cardiac surgery: Data from an implantable continuous cardiac monitor. J Cardiothorac Vasc Anesth 28 (2014), 1278–1284.
4. 4 Maganti, M.D., Rao, V., Borger, M.A., et al. Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation 112 (2005), I448–452.
5. 5 Maganti, M., Badiwala, M., Sheikh, A., et al. Predictors of low cardiac output syndrome after isolated mitral valve surgery. J Thorac Cardiovasc Surg 140 (2010), 790–796.
6. 6 Vincent, J.-L., De Backer, D., Circulatory shock. N Engl J Med 369 (2013), 1726–1734.
7. 7 Algarni, K.D., Maganti, M., Yau, T.M., Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: Trends over 20 years. Ann Thorac Surg 92 (2011), 1678–1684.
8. 8 Rihal, C.S., Naidu, S.S., Givertz, M.M., et al. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino America. J Am Coll Cardiol 65 (2015), e7–26.
9. 9 Landoni, G., Bove, T., Crivellari, M., et al. Acute renal failure after isolated CABG surgery: Six years of experience. Minerva Anestesiol 73 (2007), 559–565.
10. 10 Newman, M.F., Mathew, J.P., Grocott, H.P., et al. Central nervous system injury associated with cardiac surgery. Lancet 368 (2006), 694–703.
11. 11 Aranki, S.F., Shaw, D.P., Adams, D.H., et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94 (1996), 390–397.
12. 12 Lahm, T., McCaslin, C.A., Wozniak, T.C., et al. Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol 56 (2010), 1435–1446.
13. 13 Hamad, M.A.S., van Straten, A.H.M., Schonberger, J.P.A.M., et al. Preoperative ejection fraction as a predictor of survival after coronary artery bypass grafting: Comparison with a matched general population. J Cardiothorac Surg, 5, 2010, 29.
14. 14 Osawa, E.A., Rhodes, A., Landoni, G., et al. Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery: A randomized clinical trial and systematic review. Crit Care Med 44 (2015), 724–733.
15. 15 Nashef, S.A., Roques, F., Michel, P., et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999), 9–13.
16. 16 Ding, W., Ji, Q., Shi, Y., et al. Predictors of low cardiac output syndrome after isolated coronary artery bypass grafting. Int Heart J 56 (2015), 144–149.
17. 17 Sá, M.P., Nogueira, J.R.C., Ferraz, P.E., et al. Risk factors for low cardiac output syndrome after coronary artery bypass grafting surgery. Rev Bras Cir Cardiovasc 27 (2012), 217–223.
18. 18 Pan, W., Hindler, K., Lee, V.V., et al. Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology 104 (2006), 441–447.
19. 19 Tolpin, D.A., Collard, C.D., Lee, V.-V., et al. Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency. J Thorac Cardiovasc Surg 138 (2009), 873–879.
20. 20 Lomivorotov, V.V., Efremov, S.M., Boboshko, V.A., et al. Evaluation of nutritional screening tools for patients scheduled for cardiac surgery. Nutrition 29 (2013), 436–442.
21. 21 Hernandez-Leiva, E., Dennis, R., Isaza, D., et al. Hemoglobin and B-type natriuretic peptide preoperative values but not inflammatory markers, are associated with postoperative morbidity in cardiac surgery: A prospective cohort analytic study. J Cardiothorac Surg, 8, 2013, 170.
22. 22 Lomivorotov, V.V., Efremov, S.M., Boboshko, V.A., et al. Preoperative total lymphocyte count in peripheral blood as a predictor of poor outcome in adult cardiac surgery. J Cardiothorac Vasc Anesth 25 (2011), 975–980.
23. 23 Cuthbertson, B.H., Croal, B.L., Rae, D., et al. N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: A prospective cohort study. Br J Anaesth 103 (2009), 647–653.
24. 24 Hutfless, R., Kazanegra, R., Madani, M., et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43 (2004), 1873–1879.
25. 25 Nozohoor, S., Nilsson, J., Luhrs, C., et al. B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement. J Cardiothorac Vasc Anesth 23 (2009), 161–165.
26. 26 Muehlschlegel, J.D., Perry, T.E., Liu, K.-Y., et al. Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery. Anesth Analg 111 (2010), 1101–1109.
27. 27 Kaplan, J.A., Reich, D.L., SJ: Kaplan's cardiac anesthesia: The echo era. ed 6, 2011, Elsevier, St Louis, MO.
28. 28 Mebazaa A, Gheorghiade M, Zannad FM, et al (eds): Acute heart failure. London, Springer London, 2008.
29. 29 Alsaddique AA, Royse CF, Founda MA, et al: Diastolic heart failure after cardiac surgery. Available at: 〈http://cdn.intechopen.com/pdfs-wm/32299.pdf〉. Accessed May 23, 2016.
30. 30 Kass, D.A., Bronzwaer, J.G.F., Paulus, W.J., What mechanisms underlie diastolic dysfunction in heart failure?. Circ Res 94 (2004), 1533–1542.
31. 31 Lappas, D.G., Skubas, N.J., Lappas, G.D., et al. Prevalence of left ventricular diastolic filling abnormalities in adult cardiac surgical patients: An intraoperative echocardiographic study. Semin Thorac Cardiovasc Surg 11 (1999), 125–133.
32. 32 Shi, Y., Denault, A.Y., Couture, P., et al. Biventricular diastolic filling patterns after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 131 (2006), 1080–1086.
33. 33 Rodeheffer, R., Miller, W., Burnett, J., Pathophysiology of circulatory failure. Giuliani, E., Gersh, B., Megoon, M., et al. (eds.) Mayo Clinic practice of clinical cardiology, ed 3, 1996, Mosby, St Louis, MO.
34. 34 Bossone, E., Bodini, B.D., Mazza, A., et al. Pulmonary arterial hypertension: The key role of echocardiography. Chest 127 (2005), 1836–1843.
35. 35 Fletcher, N., Geisen, M., Meeran, H., et al. Initial clinical experience with a miniaturized transesophageal echocardiography probe in a cardiac intensive care unit. J Cardiothorac Vasc Anesth 29 (2015), 582–587.
36. 36 Zochios, V., Jones, N., Acute right heart syndrome in the critically ill patient. Heart Lung Vessel 6 (2014), 157–170.
37. 37 Brooks, H., Kirk, E.S., Vokonas, P.S., et al. Performance of the right ventricle under stress: Relation to right coronary flow. J Clin Invest 50 (1971), 2176–2183.
38. 38 Price, L.C., Wort, S.J., Finney, S.J., et al. Pulmonary vascular and right ventricular dysfunction in adult critical care: Current and emerging options for management: A systematic literature review. Crit Care, 14, 2010, R169.
39. 39 Pfisterer, M., Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet 362 (2003), 392–394.
40. 40 Jozwiak, M., Monnet, X., Teboul, J.-L., Monitoring: From cardiac output monitoring to echocardiography. Curr Opin Crit Care 21 (2015), 395–401.
41. 41 Guarracino, F., Bertini, P., Perioperative haemodynamic management: Is echocardiography the right tool?. Curr Opin Crit Care 20 (2014), 431–437.
42. 42 Judge, O., Ji, F., Fleming, N., et al. Current use of the pulmonary artery catheter in cardiac surgery: A survey study. J Cardiothorac Vasc Anesth 29 (2015), 69–75.
43. 43 American Society of Anesthesiologists and Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography: Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 112 (2010), 1084–1096.
44. 44 Cecconi, M., De Backer, D., Antonelli, M., et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 40 (2014), 1795–1815.
45. 45 Mebazaa, A., Tolppanen, H., Mueller, C., et al. Acute heart failure and cardiogenic shock: A multidisciplinary practical guidance. Intensive Care Med 42 (2016), 147–163.
46. 46 Peeters, Y., Bernards, J., Mekeirele, M., et al. Hemodynamic monitoring: To calibrate or not to calibrate? Part 1 - Calibrated techniques. Anaesthesiol Intensive Ther 47 (2015), 487–500.
47. 47 Bernards, J., Mekeirele, M., Hoffmann, B., et al. Hemodynamic monitoring: To calibrate or not to calibrate? Part 2 - Non-calibrated techniques. Anaesthesiol Intensive Ther 47 (2015), 501–516.
48. 48 Tan, H.L., Pinder, M., Parsons, R., et al. Clinical evaluation of USCOM ultrasonic cardiac output monitor in cardiac surgical patients in intensive care unit. Br J Anaesth 94 (2005), 287–291.
49. 49 Arora, D., Chand, R., Mehta, Y., et al. Cardiac output estimation after off-pump coronary artery bypass: A comparison of two different techniques. Ann Card Anaesth 10 (2007), 132–136.
50. 50 Peyton, P.J., Chong, S.W., Minimally invasive measurement of cardiac output during surgery and critical care: A meta-analysis of accuracy and precision. Anesthesiology 113 (2010), 1220–1235.
51. 51 Chiang, Y., Hosseinian, L., Rhee, A., et al. Questionable benefit of the pulmonary artery catheter after cardiac surgery in high-risk patients. J Cardiothorac Vasc Anesth 29 (2015), 76–81.
52. 52 Kirov, M.Y., Kuzkov, V.V., Molnar, Z., Perioperative haemodynamic therapy. Curr Opin Crit Care 16 (2010), 384–392.
53. 53 Kirov, M.Y., Kuzkov, V.V., Bjertnaes, L.J., Extravascular lung water as a target for goal-directed therapy?. Vincent, J.L., (eds.) Annual update in intensive care emergency medicine, 2014, Springer International Publishing, Cham, Switzerland, 285–298.
54. 54 Kirov, M.Y., Lenkin, A.I., Kuzkov, V.V., et al. Single transpulmonary thermodilution in off-pump coronary artery bypass grafting: Haemodynamic changes and effects of different anaesthetic techniques. Acta Anaesthesiol Scand 51 (2007), 426–433.
55. 55 Monnet, X., Persichini, R., Ktari, M., et al. Precision of the transpulmonary thermodilution measurements. Crit Care, 15, 2011, R204.
56. 56 Schmid B, Fink K, Olschewski M, etal: Accuracy and precision of transcardiopulmonary thermodilution in patients with cardiogenic shock. J Clin Monit Comput 2015 Oct 1 [Epub ahead of print].
57. 57 Hamzaoui, O., Monnet, X., Richard, C., et al. Effects of changes in vascular tone on the agreement between pulse contour and transpulmonary thermodilution cardiac output measurements within an up to 6-hour calibration-free period. Crit Care Med 36 (2008), 434–440.
58. 58 Broch, O., Renner, J., Höcker, J., et al. Uncalibrated pulse power analysis fails to reliably measure cardiac output in patients undergoing coronary artery bypass surgery. Crit Care, 15, 2011, R76.
59. 59 Belda, F.J., Aguilar, G., Teboul, J.L., et al. Complications related to less-invasive haemodynamic monitoring. Br J Anaesth 106 (2011), 482–486.
60. 60 Linton, R.A., Band, D.M., Haire, K.M., A new method of measuring cardiac output in man using lithium dilution. Br J Anaesth 71 (1993), 262–266.
61. 61 Phan, T.D., Kluger, R., Wan, C., et al. A comparison of three minimally invasive cardiac output devices with thermodilution in elective cardiac surgery. Anaesth Intensive Care 39 (2011), 1014–1021.
62. 62 Desebbe, O., Henaine, R., Keller, G., et al. Ability of the third-generation FloTrac/Vigileo software to track changes in cardiac output in cardiac surgery patients: A polar plot approach. J Cardiothorac Vasc Anesth 27 (2013), 1122–1127.
63. 63 Smetkin, A.A., Hussain, A., Kuzkov, V.V., et al. Validation of cardiac output monitoring based on uncalibrated pulse contour analysis vs transpulmonary thermodilution during off-pump coronary artery bypass grafting. Br J Anaesth 112 (2014), 1024–1031.
64. 64 Broch, O., Carbonell, J., Ferrando, C., et al. Accuracy of an autocalibrated pulse contour analysis in cardiac surgery patients: A bi-center clinical trial. BMC Anesthesiol, 15, 2015, 171.
65. 65 Romano, S.M., Pistolesi, M., Assessment of cardiac output from systemic arterial pressure in humans. Crit Care Med 30 (2002), 1834–1841.
66. 66 Giomarelli, P., Biagioli, B., Scolletta, S., Cardiac output monitoring by pressure recording analytical method in cardiac surgery. Eur J Cardiothorac Surg 26 (2004), 515–520.
67. 67 Barile, L., Landoni, G., Pieri, M., et al. Cardiac index assessment by the pressure recording analytic method in critically ill unstable patients after cardiac surgery. J Cardiothorac Vasc Anesth 27 (2013), 1108–1113.
68. 68 Paarmann, H., Groesdonk, H.V., Sedemund-Adib, B., et al. Lack of agreement between pulmonary arterial thermodilution cardiac output and the pressure recording analytical method in postoperative cardiac surgery patients. Br J Anaesth 106 (2011), 475–481.
69. 69 Urbano, J., López, J., González, R., et al. Measurement of cardiac output in children by pressure-recording analytical method. Pediatr Cardiol 36 (2015), 358–364.
70. 70 Stephens, R.S., Whitman, G.J.R., Postoperative critical care of the adult cardiac surgical patient. Part I: Routine postoperative care. Crit Care Med 43 (2015), 1477–1497.
71. 71 Greenberg, S.B., Murphy, G.S., Vender, J.S., Current use of the pulmonary artery catheter. Curr Opin Crit Care 15 (2009), 249–253.
72. 72 Schwann TA, Zacharias A, Riordan CJ, et al. Safe, highly selective use of pulmonary artery catheters in coronary artery bypass grafting: An objective patient selection method. Ann Thorac Surg 73:1394–1401.
73. 73 Bisgaard, J., Gilsaa, T., Rønholm, E., et al. Optimising stroke volume and oxygen delivery in abdominal aortic surgery: A randomised controlled trial. Acta Anaesthesiol Scand 57 (2013), 178–188.
74. 74 Resano, F.G., Kapetanakis, E.I., Hill, P.C., et al. Clinical outcomes of low-risk patients undergoing beating-heart surgery with or without pulmonary artery catheterization. J Cardiothorac Vasc Anesth 20 (2006), 300–306.
75. 75 Bonazzi, M., Gentile, F., Biasi, G.M., et al. Impact of perioperative haemodynamic monitoring on cardiac morbidity after major vascular surgery in low risk patients. A randomised pilot trial. Eur J Vasc Endovasc Surg 23 (2002), 445–451.
76. 76 McKendry, M., McGloin, H., Saberi, D., et al. Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery. BMJ, 329, 2004, 258.
77. 77 Pölönen, P., Ruokonen, E., Hippeläinen, M., et al. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 90 (2000), 1052–1059.
78. 78 Kapoor, P.M., Kakani, M., Chowdhury, U., et al. Early goal-directed therapy in moderate to high-risk cardiac surgery patients. Ann Card Anaesth 11 (2008), 27–34.
79. 79 Goepfert, M.S., Reuter, D.A., Akyol, D., et al. Goal-directed fluid management reduces vasopressor and catecholamine use in cardiac surgery patients. Intensive Care Med 33 (2007), 96–103.
80. 80 Smetkin, A.A., Kirov, M.Y., Kuzkov, V.V., et al. Single transpulmonary thermodilution and continuous monitoring of central venous oxygen saturation during off-pump coronary surgery. Acta Anaesthesiol Scand 53 (2009), 505–514.
81. 81 Giglio, M., Dalfino, L., Puntillo, F., et al. Haemodynamic goal-directed therapy in cardiac and vascular surgery. A systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 15 (2012), 878–887.
82. 82 Aya, H.D., Cecconi, M., Hamilton, M., et al. Goal-directed therapy in cardiac surgery: A systematic review and meta-analysis. Br J Anaesth 110 (2013), 510–517.
83. 83 Lobo, S.M., Salgado, P.F., Castillo, V.G., et al. Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 28 (2000), 3396–3404.
84. 84 Goepfert, M.S., Richter, H.P., Zu Eulenburg, C., et al. Individually optimized hemodynamic therapy reduces complications and length of stay in the intensive care unit: A prospective, randomized controlled trial. Anesthesiology 119 (2013), 824–836.
85. 85 Lenkin, A.I., Kirov, M.Y., Kuzkov, V.V., et al. Comparison of goal-directed hemodynamic optimization using pulmonary artery catheter and transpulmonary thermodilution in combined valve repair: A randomized clinical trial. Crit Care Res Pract, 2012, 2012, 821218.
86. 86 Melrose, D.G., Dreyer, B., Bentall, H.H., et al. Elective cardiac arrest. Lancet 269 (1955), 21–22.
87. 87 Zeng, J., He, W., Qu, Z., et al. Cold blood versus crystalloid cardioplegia for myocardial protection in adult cardiac surgery: A meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 28 (2014), 674–681.
88. 88 Mallidi, H.R., Sever, J., Tamariz, M., et al. The short-term and long-term effects of warm or tepid cardioplegia. J Thorac Cardiovasc Surg 125 (2003), 711–720.
89. 89 Martin, T.D., Craver, J.M., Gott, J.P., et al. Prospective, randomized trial of retrograde warm blood cardioplegia: Myocardial benefit and neurologic threat. Ann Thorac Surg 57 (1994), 298–302.
90. 90 Algarni, K.D., Weisel, R.D., Caldarone, C.A., et al. Microplegia during coronary artery bypass grafting was associated with less low cardiac output syndrome: A propensity-matched comparison. Ann Thorac Surg 95 (2013), 1532–1538.
91. 91 McCann, U.G., Lutz, C.J., Picone, A.L., et al. Whole blood cardioplegia (minicardioplegia) reduces myocardial edema after ischemic injury and cardiopulmonary bypass. J Extra Corpor Technol 38 (2006), 14–21.
92. 92 Hillis, L.D., Smith, P.K., Anderson, J.L., et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124 (2011), 2610–2642.
93. 93 Landoni, G., Biondi-Zoccai, G.G.L., Zangrillo, A., et al. Desflurane and sevoflurane in cardiac surgery: A meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 21 (2007), 502–511.
94. 94 Ranucci, M., Castelvecchio, S., Biondi, A., et al. A randomized controlled trial of preoperative intra-aortic balloon pump in coronary patients with poor left ventricular function undergoing coronary artery bypass surgery. Crit Care Med 41 (2013), 2476–2483.
95. 95 Santarpino, G., Onorati, F., Rubino, A.S., et al. Preoperative intraaortic balloon pumping improves outcomes for high-risk patients in routine coronary artery bypass graft surgery. Ann Thorac Surg 87 (2009), 481–488.
96. 96 Ranucci, M., Ballotta, A., Castelvecchio, S., et al. Perioperative heart failure in coronary surgery and timing of intra-aortic balloon pump insertion. Acta Anaesthesiol Scand 54 (2010), 878–884.
97. 97 Pilarczyk, K., Boening, A., Jakob, H., et al. Preoperative intra-aortic counterpulsation in high-risk patients undergoing cardiac surgery: A meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg 49 (2016), 5–17.
98. 98 Morkin, E., Flink, I.L., Goldman, S., Biochemical and physiologic effects of thyroid hormone on cardiac performance. Prog Cardiovasc Dis 25 (1983), 435–464.
99. 99 Haas, N.A., Camphausen, C.K., Kececioglu, D., Clinical review: Thyroid hormone replacement in children after cardiac surgery—is it worth a try?. Crit Care, 10, 2006, 213.
100. 100 Holland, F.W., Brown, P.S., Weintraub, B.D., et al. Cardiopulmonary bypass and thyroid function: A “euthyroid sick syndrome.”. Ann Thorac Surg 52 (1991), 46–50.
101. 101 Cerillo, A.G., Storti, S., Kallushi, E., et al. The low triiodothyronine syndrome: A strong predictor of low cardiac output and death in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 97 (2014), 2089–2095.
102. 102 Mullis-Jansson, S.L., Argenziano, M., Corwin, S., et al. A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg 117 (1999), 1128–1134.
103. 103 Choi, Y.S., Shim, J.K., Song, J.W., et al. Efficacy of perioperative oral triiodothyronine replacement therapy in patients undergoing off-pump coronary artery bypass grafting. J Cardiothorac Vasc Anesth 27 (2013), 1218–1223.
104. 104 Choi, Y.S., Kwak, Y.L., Kim, J.C., et al. Peri-operative oral triiodothyronine replacement therapy to prevent postoperative low triiodothyronine state following valvular heart surgery. Anaesthesia 64 (2009), 871–877.
105. 105 Nielsen, D.V., Hansen, M.K., Johnsen, S.P., et al. Health outcomes with and without use of inotropic therapy in cardiac surgery: Results of a propensity score-matched analysis. Anesthesiology 120 (2014), 1098–1108.
106. 106 Bayram, M., De Luca, L., Massie, M.B., et al. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 96 (2005), 47G–58G.
107. 107 MacGregor, D.A., Smith, T.E., Prielipp, R.C., et al. Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology 92 (2000), 338–346.
108. 108 Packer, M., Medina, N., Yushak, M., Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation 70 (1984), 1038–1047.
109. 109 Huckauf, H., Ramdohr, B., Schröder, R., Dopamine induced hypoxemia in patients with left heart failure. Int J Clin Pharmacol Biopharm 14 (1976), 217–224.
110. 110 O'Regan, R.G., Majcherczyk, S., Role of peripheral chemoreceptors and central chemosensitivity in the regulation of respiration and circulation. J Exp Biol 100 (1982), 23–40.
111. 111 Johnson, R.L., Low-dose dopamine and oxygen transport by the lung. Circulation 98 (1998), 97–99.
112. 112 van de Borne, P., Oren, R., Somers, V.K., Dopamine depresses minute ventilation in patients with heart failure. Circulation 98 (1998), 126–131.
113. 113 Marik, P.E., Iglesias, J., Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORASEPT II Study Investigators. Am J Med 107 (1999), 387–390.
114. 114 Bellomo, R., Chapman, M., Finfer, S., et al. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356 (2000), 2139–2143.
115. 115 Kellum, J.A., M Decker, J: Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 29 (2001), 1526–1531.
116. 116 Tuttle, R.R., Mills, J., Dobutamine: Development of a new catecholamine to selectively increase cardiac contractility. Circ Res 36 (1975), 185–196.
117. 117 Ruffolo, R.R., The pharmacology of dobutamine. Am J Med Sci 294 (1987), 244–248.
118. 118 Leier, C.V., Webel, J., Bush, C.A., The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation 56 (1977), 468–472.
119. 119 Jewitt, D., Birkhead, J., Mitchell, A., et al. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine. Lancet 2 (1974), 363–367.
120. 120 Barbato, E., Bartunek, J., Wyffels, E., et al. Effects of intravenous dobutamine on coronary vasomotion in humans. J Am Coll Cardiol 42 (2003), 1596–1601.
121. 121 Meyer, S.L., Curry, G.C., Donsky, M.S., et al. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol 38 (1976), 103–108.
122. 122 Rahimtoola, S.H., Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation 94 (1996), 3055–3061.
123. 123 Richard, C., Ricome, J.L., Rimailho, A., et al. Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock. Circulation 67 (1983), 620–626.
124. 124 Martin, C., Viviand, X., Leone, M., et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28 (2000), 2758–2765.
125. 125 Martin, C., Papazian, L., Perrin, G., et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?. Chest 103 (1993), 1826–1831.
126. 126 Fukuoka, T., Nishimura, M., Imanaka, H., et al. Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels. Crit Care Med 17 (1989), 1104–1107.
127. 127 Martin, C., Eon, B., Saux, P., et al. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 18 (1990), 282–285.
128. 128 Takala, J., Determinants of splanchnic blood flow. Br J Anaesth 77 (1996), 50–58.
129. 129 Totaro, R.J., Raper, R.F., Epinephrine-induced lactic acidosis following cardiopulmonary bypass. Crit Care Med 25 (1997), 1693–1699.
130. 130 Kemp, S.F., Lockey, R.F., Simons, F.E.R., Epinephrine: The drug of choice for anaphylaxis. A statement of the World. Allergy Organization. Allergy 63 (2008), 1061–1070.
131. 131 Senz, A., Nunnink, L., Review article: Inotrope and vasopressor use in the emergency department. Emerg Med Australas 21 (2009), 342–351.
132. 132 Reinelt, H., Radermacher, P., Kiefer, P., et al. Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 27 (1999), 325–331.
133. 133 Shanmugam, G., Vasoplegic syndrome—the role of methylene blue. Eur J Cardiothorac Surg 28 (2005), 705–710.
134. 134 Kristof, A.S., Magder, S., Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass. Crit Care Med 27 (1999), 1121–1127.
135. 135 Parissis, J.T., Farmakis, D., Nieminen, M., Classical inotropes and new cardiac enhancers. Heart Fail Rev 12 (2007), 149–156.
136. 136 Movsesian, M., Stehlik, J., Vandeput, F., et al. Phosphodiesterase inhibition in heart failure. Heart Fail Rev 14 (2009), 255–263.
137. 137 Mebazaa, A., Parissis, J., Porcher, R., et al. Short-term survival by treatment among patients hospitalized with acute heart failure: The global ALARM-HF registry using propensity scoring methods. Intensive Care Med 37 (2011), 290–301.
138. 138 Metra, M., Eichhorn, E., Abraham, W.T., et al. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: The randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. Eur Heart J 30 (2009), 3015–3026.
139. 139 Packer, M., Carver, J.R., Rodeheffer, R.J., et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325 (1991), 1468–1475.
140. 140 Abraham, W.T., Adams, K.F., Fonarow, G.C., et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 46 (2005), 57–64.
141. 141 Majure, D.T., Greco, T., Greco, M., et al. Meta-analysis of randomized trials of effect of milrinone on mortality in cardiac surgery: An update. J Cardiothorac Vasc Anesth 27 (2013), 220–229.
142. 142 Zangrillo, A., Biondi-Zoccai, G., Ponschab, M., et al. Milrinone and mortality in adult cardiac surgery: A meta-analysis. J Cardiothorac Vasc Anesth 26 (2012), 70–77.
143. 143 Fleming, G.A., Murray, K.T., Yu, C., et al. Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. Circulation 118 (2008), 1619–1625.
144. 144 Denault, A.Y., Lamarche, Y., Couture, P., et al. Inhaled milrinone: A new alternative in cardiac surgery?. Semin Cardiothorac Vasc Anesth 10 (2006), 346–360.
145. 145 Wang, H., Gong, M., Zhou, B., et al. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. Adv Ther 26 (2009), 462–846.
146. 146 Ichinose, F., Roberts, J.D., Zapol, W.M., Inhaled nitric oxide: A selective pulmonary vasodilator: Current uses and therapeutic potential. Circulation 109 (2004), 3106–3111.
147. 147 De Wet, C.J., Affleck, D.G., Jacobsohn, E., et al. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 127 (2004), 1058–1067.
148. 148 Slawsky, M.T., Colucci, W.S., Gottlieb, S.S., et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 102 (2000), 2222–2227.
149. 149 Haikala, H., Nissinen, E., Etemadzadeh, E., et al. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 25 (1995), 794–801.
150. 150 Lilleberg, J., Nieminen, M.S., Akkila, J., et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 19 (1998), 660–668.
151. 151 Michaels, A.D., McKeown, B., Kostal, M., et al. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake. Circulation 111 (2005), 1504–1509.
152. 152 du Toit, E.F., Genis, A., Opie, L.H., et al. A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart. Br J Pharmacol 154 (2008), 41–50.
153. 153 Hönisch, A., Theuring, N., Ebner, B., et al. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol 105 (2010), 155–167.
154. 154 Landoni, G., Biondi-Zoccai, G., Greco, M., et al. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med 40 (2012), 634–646.
155. 155 Zangrillo, A., Putzu, A., Monaco, F., et al. Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials. J Crit Care 30 (2016), 908–913.
156. 156 Bove, T., Matteazzi, A., Belletti, A., et al. Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: A meta-analysis of randomized clinical trials. Heart Lung Vessel 7 (2015), 35–46.
157. 157 Labriola, C., Siro-Brigiani, M., Carrata, F., et al. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery. Int J Clin Pharmacol Ther 42 (2004), 204–211.
158. 158 Levin, R.L., Degrange, M.A., Porcile, R., et al. The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome. Rev Esp Cardiol 61 (2008), 471–479.
159. 159 Toller, W., Heringlake, M., Guarracino, F., et al. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion. Int J Cardiol 184 (2015), 323–336.
160. 160 Zangrillo, A., Alvaro, G., Pisano, A., et al. A randomized controlled trial of levosimendan to reduce mortality in high risk cardiac surgery patients (CHEETAH): Rationale and design. Am Heart J 177 (2016), 66–73.
161. 161 Tritapepe, L., De Santis, V., Vitale, D., et al. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 102 (2009), 198–204.
162. 162 Levin, R., Degrange, M., Del Mazo, C., et al. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol 17 (2012), 125–130.
163. 163 Lahtinen, P., Pitkänen, O., Pölönen, P., et al. Levosimendan reduces heart failure after cardiac surgery: A prospective, randomized, placebo-controlled trial. Crit Care Med 39 (2011), 2263–2270.
164. 164 Lomivorotov, V.V., Boboshko, V.A., Efremov, S.M., et al. Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients. J Cardiothorac Vasc Anesth 26 (2012), 596–603.
165. 165 Szabó, Z., Håkanson, E., Maros, T., et al. High-dose glucose-insulin-potassium after cardiac surgery: A retrospective analysis of clinical safety issues. Acta Anaesthesiol Scand 47 (2003), 383–390.
166. 166 Svedjeholm, R., Huljebrant, I., Håkanson, E., et al. Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations. Ann Thorac Surg 59 (1995), S23–30.
167. 167 Fan, Y., Zhang, A.-M., Xiao, Y.-B., et al. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: A meta-analysis. Eur J Cardiothorac Surg 40 (2011), 192–199.
168. 168 Ali-Hassan-Sayegh, S., Mirhosseini, S.J., Zeriouh, M., et al. Safety and efficacy of glucose-insulin-potassium treatment in coronary artery bypass graft surgery and percutaneous coronary intervention. Interact Cardiovasc Thorac Surg 21 (2015), 667–676.
169. 169 Heinze, H., Heringlake, M., Schmucker, P., et al. Effects of intra-aortic balloon counterpulsation on parameters of tissue oxygenation. Eur J Anaesthesiol 23 (2006), 555–562.
170. 170 Parissis, H., Leotsinidis, M., Akbar, M.T., et al. The need for intra aortic balloon pump support following open heart surgery: Risk analysis and outcome. J Cardiothorac Surg, 5, 2010, 20.
171. 171 den Uil, C.A., Valk, S.D.A., Cheng, J.M., et al. Prognosis of patients undergoing cardiac surgery and treated with intra-aortic balloon pump counterpulsation prior to surgery: A long-term follow-up study. Interact Cardiovasc Thorac Surg 9 (2009), 227–231.
172. 172 Arafa, O.E., Geiran, O.R., Andersen, K., et al. Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg 70 (2000), 1587–1593.
173. 173 Boeken, U., Feindt, P., Litmathe, J., et al. Intraaortic balloon pumping in patients with right ventricular insufficiency after cardiac surgery: Parameters to predict failure of IABP support. Thorac Cardiovasc Surg 57 (2009), 324–328.
174. 174 Liakopoulos, O.J., Ho, J.K., Yezbick, A.B., et al. Right ventricular failure resulting from pressure overload: Role of intra-aortic balloon counterpulsation and vasopressor therapy. J Surg Res 164 (2010), 58–66.
175. 175 Vanden Eynden, F., Mets, G., De Somer, F., et al. Is there a place for intra-aortic balloon counterpulsation support in acute right ventricular failure by pressure-overload?. Int J Cardiol 197 (2015), 227–234.
176. 176 Meharwal, Z.S., Trehan, N., Vascular complications of intra-aortic balloon insertion in patients undergoing coronary reavscularization: Analysis of 911 cases. Eur J Cardiothorac Surg 21 (2002), 741–747.
177. 177 Cohen, M., Urban, P., Christenson, J.T., et al. Intra-aortic balloon counterpulsation in US and non-US centres: Results of the Benchmark Registry. Eur Heart J 24 (2003), 1763–1770.
178. 178 Thiele, H., Zeymer, U., Neumann, F.J., et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367 (2012), 1287–1296.
179. 179 Patel, M.R., Smalling, R.W., Thiele, H., et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: The CRISP AMI randomized trial. JAMA 306 (2011), 1329–1337.
180. 180 Perera, D., Stables, R., Thomas, M., et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: A randomized controlled trial. JAMA 304 (2010), 867–874.
181. 181 Thiele, H., Zeymer, U., Neumann, F.J., et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): Final 12 month results of a randomised, open-label trial. Lancet 382 (2013), 1638–1645.
182. 182 Kolh, P., Windecker, S., Alfonso, F., et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution. Eur J Cardiothorac Surg 46 (2014), 517–592.
183. 183 Koprivanac, M., Kelava, M., Soltesz, E., et al. Advances in temporary mechanical support for treatment of cardiogenic shock. Expert Rev Med Devices 12 (2015), 689–702.
184. 184 Pulido, J.N., Park, S.J., Rihal, C.S., Percutaneous left ventricular assist devices: Clinical uses, future applications, and anesthetic considerations. J Cardiothorac Vasc Anesth 24 (2010), 478–486.
185. 185 Tramm, R., Ilic, D., Davies, A.R., et al. Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database Syst Rev, 1, 2015, CD010381.
186. 186 Rastan, A.J., Dege, A., Mohr, M., et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 139 (2010), 302–311.
187. 187 Smith, C., Bellomo, R., Raman, J.S., et al. An extracorporeal membrane oxygenation-based approach to cardiogenic shock in an older population. Ann Thorac Surg 71 (2001), 1421–1427.
188. 188 Bakhtiary, F., Keller, H., Dogan, S., et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: Clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg 135 (2008), 382–388.
189. 189 Zhang, R., Kofidis, T., Kamiya, H., et al. Creatine kinase isoenzyme MB relative index as predictor of mortality on extracorporeal membrane oxygenation support for postcardiotomy cardiogenic shock in adult patients. Eur J Cardiothorac Surg 30 (2006), 617–620.
190. 190 Xie, A., Phan, K., Tsai, Y.-C., et al. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: A meta-analysis. J Cardiothorac Vasc Anesth 29 (2015), 637–645.
191. 191 Extracorporeal Life Support Organization registry report (international summary), Ann Arbor, MI, Extracorporeal Life Support Organization, January, 2016, p 17.
192. 192 Montgomery, V.L., Strotman, J.M., Ross, M.P., Impact of multiple organ system dysfunction and nosocomial infections on survival of children treated with extracorporeal membrane oxygenation after heart surgery. Crit Care Med 28 (2000), 526–531.
193. 193 Schutze, G.E., Heulitt, M.J., Infections during extracorporeal life support. J Pediatr Surg 30 (1995), 809–812.
194. 194 Nasr, D.M., Rabinstein, A.A., Neurologic complications of extracorporeal membrane oxygenation. J Clin Neurol 11 (2015), 383–389.
195. 195 Doll, N., Kiaii, B., Borger, M., et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 77 (2004), 151–157.
196. 196 Basra, S.S., Loyalka, P., Kar, B., Current status of percutaneous ventricular assist devices for cardiogenic shock. Curr Opin Cardiol 26 (2011), 548–554.
197. 197 Griffith, B.P., Anderson, M.B., Samuels, L.E., et al. The RECOVER I: A multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg 145 (2013), 548–554.
198. 198 Gaudard, P., Mourad, M., Eliet, J., et al. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Crit Care, 19, 2015, 363.
199. 199 Lamarche, Y., Cheung, A., Ignaszewski, A., et al. Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support. J Thorac Cardiovasc Surg 142 (2011), 60–65.
200. 200 Lauten, A., Engström, A.E., Jung, C., et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: Results of the Impella-EUROSHOCK-registry. Circ Heart Fail 6 (2013), 23–30.
201. 201 Anderson, M.B., Goldstein, J., Milano, C., et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 34 (2015), 1549–1560.
202. 202 Borisenko, O., Wylie, G., Payne, J., et al. Thoratec CentriMag for temporary treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency: A systematic literature review and meta-analysis of observational studies. ASAIO J 60 (2014), 487–497.
203. 203 Bhama, J.K., Kormos, R.L., Toyoda, Y., et al. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant 28 (2009), 971–976.
204. 204 Kar, B., Gregoric, I.D., Basra, S.S., et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol 57 (2011), 688–696.
205. 205 Burkhoff, D., Cohen, H., Brunckhorst, C., et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J, 152, 2006, 469.e1-8.
206. 206 Giesler, G.M., Gomez, J.S., Letsou, G., et al. Initial report of percutaneous right ventricular assist for right ventricular shock secondary to right ventricular infarction. Catheter Cardiovasc Interv 68 (2006), 263–266.
207. 207 Kapur, N.K., Paruchuri, V., Korabathina, R., et al. Effects of a percutaneous mechanical circulatory support device for medically refractory right ventricular failure. J Heart Lung Transplant 30 (2011), 1360–1367.